Background: Application of adjuvants with microbial origins is a recently highlighted approach in the vaccinology trials. Archaeosomes are among these microbial compounds with both adjuvant and liposomal activities and features.
Methods: In the present study, recombinant HBsAg encapsulated into Methanobrevibacter smithii (M.